Search Results - "Sitti, Wanlaya"

Use of drug-susceptibility testing for management of drug-resistant tuberculosis, Thailand, 2004-2008 by Lam, Eugene, Nateniyom, Sriprapa, Whitehead, Sara, Anuwatnonthakate, Amornrat, Monkongdee, Patama, Kanphukiew, Apiratee, Inyaphong, Jiraphan, Sitti, Wanlaya, Chiengsorn, Navarat, Moolphate, Saiyud, Kavinum, Suporn, Suriyon, Narin, Limsomboon, Pranom, Danyutapolchai, Junya, Sinthuwattanawibool, Chalinthorn, Podewils, Laura Jean

“…In 2004, routine use of culture and drug-susceptibility testing (DST) was implemented for persons in 5 Thailand provinces with a diagnosis of tuberculosis…”
Get full text

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance by Cegielski, J. Peter, Kurbatova, Ekaterina, van der Walt, Martie, Brand, Jeannette, Ershova, Julia, Tupasi, Thelma, Caoili, Janice Campos, Dalton, Tracy, Contreras, Carmen, Yagui, Martin, Bayona, Jaime, Kvasnovsky, Charlotte, Leimane, Vaira, Kuksa, Liga, Chen, Michael P., Via, Laura E., Hwang, Soo Hee, Wolfgang, Melanie, Volchenkov, Grigory V., Somova, Tatiana, Smith, Sarah E., Akksilp, Somsak, Wattanaamornkiet, Wanpen, Kim, Hee Jin, Kim, Chang-ki, Kazennyy, Boris Y., Khorosheva, Tatiana, Kliiman, Kai, Viiklepp, Piret, Jou, Ruwen, Huang, Angela Song-En, Vasilyeva, Irina A., Demikhova, Olga V.

“…Background. Resistance to second-line drugs develops during treatment of multidrug-resistant (MDR) tuberculosis, but the impact on treatment outcome has not…”
Get full text

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study by Dalton, Tracy, Dr, Cegielski, Peter, MD, Akksilp, Somsak, MD, Asencios, Luis, MPH, Caoili, Janice Campos, MD, Cho, Sang-Nae, Prof, Erokhin, Vladislav V, MD, Ershova, Julia, PhD, Gler, Ma Tarcela, MD, Kazennyy, Boris Y, MD, Kim, Hee Jin, MD, Kliiman, Kai, MD, Kurbatova, Ekaterina, MD, Kvasnovsky, Charlotte, MD, Leimane, Vaira, MD, van der Walt, Martie, PhD, Via, Laura E, PhD, Volchenkov, Grigory V, MD, Yagui, Martin A, MD, Kang, Hyungseok, MD

“…Summary Background The prevalence of extensively drug-resistant (XDR) tuberculosis is increasing due to the expanded use of second-line drugs in people with…”
Get full text

Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters by Cavanaugh, Joseph S, Jou, Ruwen, Wu, Mei-Hua, Dalton, Tracy, Kurbatova, Ekaterina, Ershova, Julia, Cegielski, J Peter

“…The second-line drugs recommended to treat drug-resistant TB are toxic, expensive and difficult to procure. Given increasing resistance, the need for…”
Get full text

Interferring Substance in Point-of-Care Testing Glucometer by Limthong Promdee, Jirawat Mingchai, Suparada Tinkachat, Wanlaya Sitti, Khaekhai Pikapaid, Sirawich Sonsok, Nongluk Champee, Chainarong Thong-aon

“…Glucometer, a point-of-care testing device for determination of blood glucose level, is widelyused in medical clinic and for self-monitoring blood glucose…”
Get full text